BioFocus' Acquisition - II

BioFocus raised a round of funding on March 13, 2014. Investors include Charles River Laboratories.

BioFocus provides integrated drug discovery that delivers pre-clinical drug candidates in all therapeutic areas with strong capabilities in neurodegenerative diseases, inflammatory diseases and rare a…

Articles about BioFocus' Acquisition - II: